We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ROVI

News List

Moderna and ROVI Ink Fill-Finish Deal contractpharma
July 14, 2020
Collaboration for fill-finish manufacturing of Moderna’s COVID-19 vaccine candidate.
Moderna teams up with ROVI to provide Covid-19 vaccine outside US pharmaceutical-technology
July 13, 2020
US-based biotechnology firm Moderna has partnered with European pharmaceutical company Laboratorios Farmacéuticos Rovi (ROVI) for finish-fill manufacturing of its Covid-19 vaccine candidate, mRNA-1273.
Moderna signs deal with Spain’s Rovi to supply potential COVID-19 vaccine outside US expresspharma
July 10, 2020
Moderna’s vaccine was among the first to be tested in humans in the United States and was found to produce protective antibodies in a small group of healthy volunteers in May.